Related Experiment Videos
Combining distribution- and anchor-based approaches to determine minimally important differences: the FACIT
Kathleen J Yost1, David T Eton
1Evanston Northwestern Healthcare Research Institute, USA.
Evaluation & the Health Professions
|April 27, 2005
Summary
Minimally important differences (MIDs) enhance the interpretation of health-related quality of life (HRQOL) scores in cancer research. This study outlines methods to establish MIDs for Functional Assessment of Chronic Illness Therapy (FACIT) instruments, improving clinical relevance.
Area of Science:
- Oncology
- Psychometrics
- Clinical Trials
Background:
- Health-related quality of life (HRQOL) is crucial in cancer care but often lacks clear interpretation for clinicians and researchers.
- Minimally important differences (MIDs) are essential for understanding the clinical significance of HRQOL score changes.
- The Functional Assessment of Chronic Illness Therapy (FACIT) measurement system is widely used to assess HRQOL in chronic illness, including cancer.
Purpose of the Study:
- To describe and exemplify methods for identifying MIDs for FACIT instruments.
- To enhance the interpretability of HRQOL scores in cancer clinical trials and treatment.
- To provide guidance for establishing MIDs for other FACIT instruments.
Main Methods:
- Employed distribution- and anchor-based approaches to identify MIDs.
- Discussed the critical assessment of anchor appropriateness.
- Offered strategies for synthesizing findings into a range of plausible MIDs.
Main Results:
- Summarized established MIDs for existing FACIT instruments.
- Provided general guidelines for estimating MIDs for new FACIT instruments.
- Illustrated the application of MIDs in research settings.
Conclusions:
- MIDs are vital for translating HRQOL data into clinically meaningful insights.
- The described methods offer a robust framework for determining MIDs within the FACIT system.
- Establishing MIDs improves the utility of HRQOL assessments in cancer research and patient care.